Dongxu Li

Dongxu Li

Auto-generated profile, based on publicly available information

Dongxu Li

Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2024 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
BZBo-Wei Zhao
Bo-Wei Zhao
XSXiao-Rui Su
Xiao-Rui Su
YYYue Yang
Yue Yang
DLDong-Xu Li
Dong-Xu Li
GLGuodong Li
Guodong Li
LHLun Hu
Lun Hu
Long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) are closely related to the treatment of human diseases. Traditional biological experiments often require time-consuming and labor-intensive in their search for mechanisms of disease. Computational methods are regarded as an effective way to predict unknown lncRNA-miRNA interactions (LMIs). However, most of them complete their tasks by mainly focusing on a single lncRNA-miRNA network without considering the complex mechanism between biomolecular in life activities, which are believed to be useful for improving the accuracy of LMI prediction. To address this, a heterogeneous information network (HIN) learning model with neighborhood-level structural representation, called HINLMI, to precisely identify LMIs. In particular, HINLMI first constructs a HIN by integrating nine interactions of five biomolecules. After that, different representation learning strategies are applied to learn the biological and network representations of lncRNAs and miRNAs in the HIN from different perspectives. Finally, HINLMI incorporates the XGBoost classifier to predict unknown LMIs using final embeddings of lncRNAs and miRNAs. Experimental results show that HINLMI yields a best performance on the real dataset when compared with state-of-the-art computational models. Moreover, several analysis experiments indicate that the simultaneous consideration of biological knowledge and network topology of lncRNAs and miRNAs allows HINLMI to accurately predict LMIs from a more comprehensive perspective. The promising performance of HINLMI also reveals that the utilization of rich heterogeneous information can provide an alternative insight for HINLMI to identify novel interactions between lncRNAs and miRNAs.

2 July 2025 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
DLDongxu Li
Dongxu Li
YYYue Yang
Yue Yang
ZCZiwen Cui
Ziwen Cui
Hengchuang YinHengchuang Yin
Hengchuang Yin
PHPeng-Wei Hu
Peng-Wei Hu
LHLun Hu
Lun Hu
Drug-drug interaction (DDI) refers to the interaction relationships between drugs. Discovering new DDIs is crucial for advancing drug development and enhancing clinical treatments. Given the significant progress achieved through graph neural networks (GNNs), network-based models have become a prevalent approach for tackling this challenge. However, current network-based approaches are incapable of seamlessly integrating a wide range of information. Motivated by this discovery, we propose a novel model, namely LLM-DDI, which aims to comprehensively tackle DDI prediction tasks by integrating various information of molecules in the BKG. LLM-DDI initially incorporates the generative pre-trained transformer (GPT) model to generate embeddings for each molecule within the biomedical knowledge graph (BKG). These embeddings encompass diverse types of information pertaining to each molecule. Subsequently, LLM-DDI utilizes a message-passing GNN framework to enhance the learning of molecular representations with the embeddings derived from GPT as input. LLM-DDI governs the propagation of information within the BKG by semantic relationships. These semantic relationships determine how information flows and is exchanged between different entities in the BKG. Finally, LLM-DDI leverages the learned drug representations to predict potential DDIs. Experiments show the effectiveness of LLM-DDI, as it achieves the best performance on two real-world datasets, providing valuable guidance for drug development and clinical treatment.

20 August 2025 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
DLDongxu Li
Dongxu Li
FZFeifan Zhao
Feifan Zhao
YYYue Yang
Yue Yang
ZCZiwen Cui
Ziwen Cui
PHPeng-Wei Hu
Peng-Wei Hu
LHLun Hu
Lun Hu
Drug-drug interactions (DDIs) represent a critical challenge in pharmacology, often leading to adverse effects and compromised therapeutic efficacy. Accurate prediction of DDI events, which involve not only identifying interacting drug pairs but also characterizing the specific nature and context of their interactions, is essential for drug safety and personalized medicine. In this study, we propose a novel Multi-view Contrastive Learning framework, namely MCL-DDI, for DDI Event Prediction by leveraging multi-view representations of drugs to enhance predictive performance. MCL-DDI integrates molecular structures and network features, capturing complementary information about drug properties and interactions. By employing contrastive learning, we align and unify drug representations across these diverse views, enabling the framework to distinguish complex interaction patterns. Extensive experiments on benchmark datasets demonstrate that MCL-DDI outperforms state-of-the-art methods in terms of predictive accuracy. Furthermore, case studies highlight the model's ability to identify clinically relevant DDIs, offering practical insights for drug development and risk assessment. Our work establishes a robust and accurate paradigm for DDI event prediction, paving the way for safer and more effective pharmacological interventions.

16 September 2025 in IEEE Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
DLDongxu Li
Dongxu Li
ZLZhenfeng Li
Zhenfeng Li
BZBo-Wei Zhao
Bo-Wei Zhao
XSXiaorui Su
Xiaorui Su
GLGuodong Li
Guodong Li
LHLun Hu
Lun Hu
Human immunodeficiency virus type 1 (HIV-1) is one of the main causative agents of acquired immunodeficiency syndrome (AIDS), and effectively identifying HIV-1 protease cleavage sites (PCSs) is of great importance for the design of new anti-AIDS inhibitors. Computational prediction of HIV-1 PCSs can be used to discover new cleavable substrates, and further facilitates the understanding of substrate specificity. A novel deep learning model, namely DeepHIV, is designed to predict HIV-1 PCSs from substrate sequence information alone. In particular, DeepHIV first applies a convolutional neural network combined with an attention mechanism to capture the rich contextual information of position-specific amino acids in the substrate sequences, thus improving the quality of features learned for substrates. Considering the imbalance observed between cleavable and uncleavable substrates, a biased support vector machine is adopted as the classifier of DeepHIV to complete the prediction task. Experimental results demonstrate that DeepHIV outperforms several state-of-the-art prediction methods across all benchmark datasets and evaluation metrics. Hence, DeepHIV is an accurate and robust tool to predict HIV-1 PCSs. Moreover, the promising predictive performance of DeepHIV also reveals that our deep learning model is capable of fully leveraging the sequence information to effectively learn the latent features of substrates.


23 November 2023 in Journal of Computational Biophysics and Chemistry
Verified
Journal Article
Closed access
BZBo-Wei Zhao
Bo-Wei Zhao
XSXiao-Rui Su
Xiao-Rui Su
DLDong-Xu Li
Dong-Xu Li
GLGuodong Li
Guodong Li
PHPeng-Wei Hu
Peng-Wei Hu
LHLun Hu
Lun Hu